Systemic and pulmonary circulatory effects of protamine following cardiopulmonary bypass in man.

The cardiovascular effects of protamine were studied in 19 men with normal left ventricular function undergoing primary myocardial revascularization. Protamine was given over 120 sec after termination of cardiopulmonary bypass. Arterial and pulmonary pressures, aortic blood flow, central venous pressure, heart rate and electrocardiogram were continuously registered. Pulmonary capillary wedge pressure was recorded at the times of maximal hemodynamic response. The systolic arterial pressure fell from 116 to 66 mmHg about 60 sec after the start of protamine infusion, but spontaneously began to rise after a few seconds, reaching 90% of pre-protamine levels at 126 sec. No inotropic drugs or volume infusion were given. At about 2 min, the mean pulmonary artery pressure rose from 16.3 to 26.2 mmHg and the central venous pressure from 7.0 to 11.4 mmHg. The heart rate and cardiac output were almost unchanged throughout. Systemic hypotension and pulmonary hypertension are suggested to represent true side effects of protamine or protamine/heparin complex. When left ventricular function is good, the hypotension reverses without treatment. Volume infusion may indeed precipitate right heart failure when the pre-load effect is added to the subsequent protamine-induced pulmonary hypertension.

[1]  A. Mazzola,et al.  Cardiorespiratory effects of protamine sulphate in man: intra-aortic vs intra-right atrial rapid administration after cardiopulmonary bypass. , 1987, The Journal of cardiovascular surgery.

[2]  P. Barash,et al.  Protamine: Does It Alter Right Ventricular Function? , 1986, Anesthesia and analgesia.

[3]  E. Blackstone,et al.  Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. , 1986, The Annals of thoracic surgery.

[4]  J. Weiler,et al.  Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody. , 1985, The Journal of thoracic and cardiovascular surgery.

[5]  P. Atkins,et al.  Management of the patient with protamine hypersensitivity for cardiac surgery. , 1984, Anesthesiology.

[6]  R. Frater,et al.  Protamine-induced circulatory changes. , 1984, The Journal of thoracic and cardiovascular surgery.

[7]  R. Novick,et al.  Toward a Better Understanding of the Hemodynamic Effects of Protamine and Heparin Interaction , 1984, The Journal of thoracic and cardiovascular surgery.

[8]  W. Daggett,et al.  Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. , 1983, Anesthesiology.

[9]  A. Pauca,et al.  Hemodynamic effects of intraaortic administration of protamine. , 1983, The Annals of thoracic surgery.

[10]  H. Schaff,et al.  Cardiovascular effects of protamine sulfate in man. , 1982, The Journal of thoracic and cardiovascular surgery.

[11]  A. Arís,et al.  Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass. , 1981, Cardiovascular diseases.

[12]  H. Macvaugh,et al.  Cardiovascular Effects of Protamine Sulfate in Man , 1981, Anesthesia and analgesia.

[13]  David C S Leong,et al.  CARDIOPULMONARY EFFECTS OF PROTAMINE IN MAN , 1980 .

[14]  J. Michenfelder Exposure to anesthetic gases and health problems in dental workers. , 1980, Anesthesiology.

[15]  M. K. Sykes,et al.  Cardiorespiratory effects of protamine after cardiopulmonary bypass in man , 1974, Thorax.

[16]  J. Horrow Thrombocytopenia accompanying a reaction to protamine sulfate , 1985, Canadian Anaesthetists' Society journal.

[17]  K. Rådegran,et al.  Mode of action of protamine in regard to its circulatory and respiratory side effects. , 1971, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.